Diagnostics
California-based Grail aims to alter the devastating trajectory of cancer mortality with the addition of one simple blood test.
Guardant Health is taking Roche-owned Foundation Medicine to court over a patent dispute for their liquid biopsy technology, further heating up the rivalry between the two cancer detection companies.
As of late, the company has already tested almost 15,000 of its 75,000 employees in a pilot program.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 24, 2020.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 17, 2020.
Abbott is suing their former VP Jerome Clavel over allegations of trade secret theft with intent to share with his new employer, rival diagnostics company Bio-Rad.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 3, 2020.
Researchers with Pfizer and IBM developed an artificial intelligence (AI) model that they claim can predict eventual onset of Alzheimer’s disease with 71% accuracy based on a language sample. They published the research today in The Lancet eClinicalMedicine.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 20, 2020.
PRESS RELEASES